Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
5(18%)
Results Posted
31%(5 trials)

Phase Distribution

Ph phase_1
7
25%
Ph phase_4
2
7%
Ph not_applicable
11
39%
Ph phase_2
4
14%
Ph phase_3
2
7%

Phase Distribution

7

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
7(26.9%)
Phase 2Efficacy & side effects
4(15.4%)
Phase 3Large-scale testing
2(7.7%)
Phase 4Post-market surveillance
2(7.7%)
N/ANon-phased studies
11(42.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

5

trials recruiting

Total Trials

28

all time

Status Distribution
Active(6)
Completed(16)
Terminated(1)
Other(5)

Detailed Status

Completed16
unknown5
Active, not recruiting3
Recruiting2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (26.9%)
Phase 24 (15.4%)
Phase 32 (7.7%)
Phase 42 (7.7%)
N/A11 (42.3%)

Trials by Status

active_not_recruiting311%
completed1657%
unknown518%
not_yet_recruiting14%
withdrawn14%
recruiting27%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT03707977Phase 1

Dual bNAb Treatment in Children

Completed
NCT05890963Phase 1

10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Active Not Recruiting
NCT05719441Phase 2

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Recruiting
NCT07418346Not Applicable

Evaluating Pain and Functional Outcomes of Active Release Technique Versus Strain-counter- Stain in Chronic Low Back Pain .A Randomized Clinical Trial

Completed
NCT04223778Phase 3

Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)

Completed
NCT05631093Phase 3

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Active Not Recruiting
NCT05528536Not Applicable

Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain

Completed
NCT06759311Not Applicable

Two Different Minimal Invasive Techniques in Caries Removal of Primary Teeth

Active Not Recruiting
NCT06591143Not Applicable

Evaluation Of Periodontal Health After Treatment With Hall Technique Versus Atraumatic Restorative Treatment in The Management of Carious Primary Molars

Not Yet Recruiting
NCT02678962Not Applicable

Comparison of Outcomes With Multifocal Intraocular Lenses

Recruiting
NCT05816096Not Applicable

ART Compared to the Hall Technique for Management HSPM

Unknown
NCT04709302

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

Unknown
NCT05244473Phase 1

A Safety Study of Brentuximab Vedotin in Participants With HIV

Withdrawn
NCT05390034Not Applicable

Improving Emotion Regulation Flexibility: Testing the Efficacy of an Emotion Regulation Program in College Students

Unknown
NCT03586128

Partners PrEP Program

Completed
NCT00000948Phase 2

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Completed
NCT03052010Phase 4

The Partners Scale-Up Project

Completed
NCT03060447Phase 1

Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers

Completed
NCT04654624Phase 2

Child Discomfort and Parental Acceptability of Silver Diamine Fluoride and Alternative Restorative Treatment

Completed
NCT04514094Not Applicable

Silver Diamine Fluoride Effectiveness Versus Atraumatic Restorative Treatment in Arresting ECC

Completed

Drug Details

Intervention Type
DRUG
Total Trials
28